Clinical Trial Update: DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating maintenance therapy with DFMO for relapsed or refractory Ewing sarcoma and osteosarcoma is currently recruiting at M…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Osteosarcoma

Drugs mentioned

• DFMO (difluoromethylornithine)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Osteosarcoma Recurrent, Ewing's Tumor Recurrent | Phase 1, Phase 2 | Status: RECRUITING